TWIST BIOSCIENCE CORP holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 3,806,867 | $149,457,598 | 0.42% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 9, 2025 |
| June 30, 2025 | 3,906,604 | $143,723,961 | 0.38% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | July 29, 2025 |
| Sept. 30, 2025 | 4,142,283 | $116,563,844 | 0.30% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 12, 2025 |
| Dec. 31, 2025 | 5,954,429 | $188,874,488 | 0.53% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 9, 2026 |
| March 31, 2026 | 5,269,718 | $250,416,999 | 0.83% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 8, 2026 |
| June 30, 2026 | 2,174,594 | $223,722,231 | 0.67% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 12, 2026 |
6 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
Twist Bioscience Corp · SC 13G/A · Event June 30, 2026 · Filed Aug. 11, 2026
| Reporting person | Reported shares | % of security class | Group box |
|---|---|---|---|
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 2,174,594.00 | 3.5% | Unavailable |
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.